ISCO stem cell production site passes building inspection
ISCO’s stem cell manufacturing facility has passed final building inspection, enabling it to implement the processes and cGMP standards needed to produce clinical-grade products.
News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs